Massachusetts Financial Services’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $474K | Buy |
44,761
+554
| +1% | +$5.86K | ﹤0.01% | 851 |
|
|
2025
Q1 | $664K | Sell |
44,207
-1,006
| -2% | -$15.1K | ﹤0.01% | 832 |
|
|
2024
Q4 | $744K | Sell |
45,213
-1,351
| -3% | -$22.2K | ﹤0.01% | 825 |
|
|
2024
Q3 | $1.15M | Sell |
46,564
-1,127
| -2% | -$27.8K | ﹤0.01% | 786 |
|
|
2024
Q2 | $1.21M | Buy |
47,691
+1,601
| +3% | +$40.6K | ﹤0.01% | 786 |
|
|
2024
Q1 | $1.17M | Buy |
+46,090
| New | +$1.17M | ﹤0.01% | 773 |
|
|
2014
Q2 | – | Sell |
-15,510
| Closed | -$637K | – | 886 |
|
|
2014
Q1 | $637K | Sell |
15,510
-14,530
| -48% | -$597K | ﹤0.01% | 805 |
|
|
2013
Q4 | $1.15M | Buy |
30,040
+12,340
| +70% | +$471K | ﹤0.01% | 709 |
|
|
2013
Q3 | $423K | Sell |
17,700
-650
| -4% | -$15.5K | ﹤0.01% | 795 |
|
|
2013
Q2 | $312K | Buy |
+18,350
| New | +$312K | ﹤0.01% | 783 |
|